Some links in this article are partner links. If you sign up through one, we may earn a commission at no cost to you. It never changes which panels we recommend or what we say about them.
One of the most common things we hear from people exploring paid research is some version of: "I looked into clinical trials, but I'm healthy — so I can't participate."
It's an understandable assumption. It's also wrong. Healthy volunteers are one of the most consistently recruited groups in all of clinical research. Before a new medication is ever tested in patients, researchers typically need to understand how it behaves in people without the condition it's meant to treat. That work depends entirely on healthy adults willing to show up.
Two more things are true, and we'll be upfront about both. First, healthy-volunteer studies — especially Phase I drug trials — often involve more testing, more restrictions, and stricter screening than almost any other kind of study. Second, they carry real medical risk. The compensation exists to recognize your time and travel, not to make risk worth ignoring. This guide covers how these studies work, what compensation typically looks like, and how to decide — with your own doctor — whether one makes sense for you.
See which trials you may qualify for →
Why research needs people who aren't sick
Most new drugs move through phases of testing. Phase I is usually the first time a compound is given to humans, and its job isn't to treat anyone. It answers safety questions: How does the body absorb and process the drug? What side effects appear at different doses? For those questions, a healthy body is the whole point — researchers want a clean baseline that isn't complicated by disease.
One piece of framing matters here, and ethical research sites will tell you the same thing: as a healthy volunteer, you're generally not expected to receive any medical benefit from participating. You're contributing data that makes future treatments possible. That's exactly why compensation exists — it's a stipend for your time, travel, and inconvenience, not a paycheck for taking a drug.
The honest trade-off: more testing, stricter screening
We'd rather tell you this now than have you discover it at a screening visit. Healthy-volunteer studies are frequently the most demanding in research:
- More procedures. Phase I protocols can involve frequent blood draws — sometimes a dozen or more in a single day around dosing — plus ECGs, scheduled vital signs, and urine collection.
- Confinement. Many Phase I studies require staying at the research facility, from one night to several weeks, so staff can monitor you and control variables like food and sleep.
- Lifestyle restrictions. Expect rules about alcohol, caffeine, smoking, certain foods, strenuous exercise, and other medications — sometimes starting weeks before dosing.
- The strictest screening in the industry. Because researchers need a clean baseline, eligibility criteria are narrow: specific age windows, BMI ranges, non-smoker status, normal lab values, and often no regular medications at all, sometimes including supplements.
Here's the honest math: most people who apply for a specific healthy-volunteer trial will not qualify for that trial. That's not a scam signal — it's the screening doing its job, and it usually says nothing about you personally. We cover the common reasons in why people get rejected from clinical trials.
Types of studies that commonly recruit healthy volunteers
We won't list specific trials here, because open studies change weekly. These are the categories where healthy adults are routinely recruited:
- Phase I safety and dosing studies. First-in-human or dose-escalation trials for new drugs. The most demanding of the bunch — and usually the most substantially compensated.
- Bioequivalence studies. These compare a generic drug to its brand-name version, typically through shorter residential stays built around repeated blood draws.
- Vaccine studies. Testing immune response and safety in healthy adults.
- Medical device and imaging studies. Researchers often need "normal" reference scans, or healthy users for wearables and monitors.
- Healthy control groups. Studies of a disease often need a comparison group without it.
- Behavioral, cognitive, and sleep studies. Often university-run; typically lower-risk and lower-paying, but easier to qualify for.
- Nutrition studies. Controlled diets, sometimes residential.
To see which of these are actually recruiting right now, browse our directory of open paid studies — or start with our clinical trials hub if you're still learning the basics.
What compensation actually looks like
Compensation in ethical research is a stipend for time, travel, and inconvenience. Ethics review boards look at the amounts partly to make sure they aren't so large that people feel pressured into accepting risk they otherwise wouldn't. That should shape your expectations: fair, sometimes substantial — never "free money."
With that frame, here's what we typically see. All of these vary enormously by location, sponsor, and protocol:
- Short outpatient visits (surveys, single blood draws, imaging): commonly roughly $25–$200 per visit.
- Multi-visit outpatient studies: commonly a few hundred dollars up to roughly $1,000–$2,000 across the full study.
- Residential Phase I studies: often calculated around roughly $150–$300 per overnight stay, with totals for multi-night studies frequently landing in the $1,000–$7,000 range depending on length and procedures. Long, multi-week residencies can run higher.
For a deeper breakdown by study type and phase, see how much clinical trials actually pay.
An illustrative breakdown — not a real person or trial
To make the trade concrete, here's a realistic example scenario: a bioequivalence study compensating around $3,000 might require one screening visit (2–3 hours), two separate three-night residential stays, blood draws every hour or two on dosing days, a follow-up outpatient visit, and no alcohol or caffeine for the duration. That's roughly eight-plus days of committed time, much of it inside a facility. Per hour, it's reasonable — but it's earned. Anyone selling healthy-volunteer trials as "easy money" is not being straight with you.
Your protections: informed consent and the right to withdraw
This is the part to know cold, because it separates legitimate research from everything else:
- IRB oversight. Legitimate US clinical trials are reviewed and approved by an Institutional Review Board — an independent committee whose job is protecting participants.
- Informed consent. Before you enroll, you'll receive a document explaining the study's purpose, every procedure, the known risks, the compensation schedule, and what happens if you're injured. Read all of it. Take it home. Ask questions until the answers make sense.
- The right to withdraw. You can leave a study at any time, for any reason, without penalty. Compensation is typically prorated for the portion you completed.
- Talk to your doctor. Before joining any study — especially a drug trial — discuss it with your own physician. We surface opportunities; the medical decision belongs to you and your doctor. And no legitimate trial will ever charge you a fee to participate.
How to get started
- Get matched. A matching service compares your basic profile against studies currently recruiting, which saves you from screening for trials you'd never qualify for.
- Browse open studies. Our directory (linked above) lists studies currently enrolling, and you can also search ClinicalTrials.gov for listings that accept healthy volunteers.
- Be honest at screening. Never downplay your health history to qualify. It puts you at genuine medical risk, and screening labs usually catch it anyway.
- Expect some no's. Qualifying is a numbers game across multiple studies over time — not a one-shot application.
Related reading
- How to get paid for clinical trials in 2026
- How much do clinical trials pay?
- Why people get rejected from clinical trials
The bottom line
You do not need a diagnosis to participate in paid research — healthy adults are the backbone of early-phase medicine. But go in clear-eyed: real testing, real restrictions, real screening, real risk, and compensation designed to respect your time rather than buy your consent. Read every consent form, involve your doctor, and treat rejection as routine.
If that trade sounds fair to you, the next step takes a few minutes: